BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23435732)

  • 1. GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.
    Gaynor KU; Grigorieva IV; Allen MD; Esapa CT; Head RA; Gopinath P; Christie PT; Nesbit MA; Jones JL; Thakker RV
    Horm Cancer; 2013 Jun; 4(3):123-39. PubMed ID: 23435732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.
    Ali A; Christie PT; Grigorieva IV; Harding B; Van Esch H; Ahmed SF; Bitner-Glindzicz M; Blind E; Bloch C; Christin P; Clayton P; Gecz J; Gilbert-Dussardier B; Guillen-Navarro E; Hackett A; Halac I; Hendy GN; Lalloo F; Mache CJ; Mughal Z; Ong AC; Rinat C; Shaw N; Smithson SF; Tolmie J; Weill J; Nesbit MA; Thakker RV
    Hum Mol Genet; 2007 Feb; 16(3):265-75. PubMed ID: 17210674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.
    Nesbit MA; Bowl MR; Harding B; Ali A; Ayala A; Crowe C; Dobbie A; Hampson G; Holdaway I; Levine MA; McWilliams R; Rigden S; Sampson J; Williams AJ; Thakker RV
    J Biol Chem; 2004 May; 279(21):22624-34. PubMed ID: 14985365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover.
    Adomas AB; Grimm SA; Malone C; Takaku M; Sims JK; Wade PA
    BMC Cancer; 2014 Apr; 14():278. PubMed ID: 24758297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome.
    Gaynor KU; Grigorieva IV; Nesbit MA; Cranston T; Gomes T; Gortner L; Thakker RV
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3897-904. PubMed ID: 19723756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of GATA3 in human breast tumors.
    Usary J; Llaca V; Karaca G; Presswala S; Karaca M; He X; Langerød A; Kåresen R; Oh DS; Dressler LG; Lønning PE; Strausberg RL; Chanock S; Børresen-Dale AL; Perou CM
    Oncogene; 2004 Oct; 23(46):7669-78. PubMed ID: 15361840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network.
    Takaku M; Grimm SA; Roberts JD; Chrysovergis K; Bennett BD; Myers P; Perera L; Tucker CJ; Perou CM; Wade PA
    Nat Commun; 2018 Mar; 9(1):1059. PubMed ID: 29535312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.
    Sereesongsaeng N; McDowell SH; Burrows JF; Scott CJ; Burden RE
    Breast Cancer Res; 2020 Dec; 22(1):139. PubMed ID: 33298139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
    Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
    Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
    Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.
    Okawa T; Yoshida M; Usui T; Kudou T; Iwasaki Y; Fukuoka K; Takahashi N; Uehara Y; Oiso Y
    BMC Endocr Disord; 2015 Oct; 15():66. PubMed ID: 26514990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome.
    Zahirieh A; Nesbit MA; Ali A; Wang K; He N; Stangou M; Bamichas G; Sombolos K; Thakker RV; Pei Y
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2445-50. PubMed ID: 15705923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells.
    Emmanuel N; Lofgren KA; Peterson EA; Meier DR; Jung EH; Kenny PA
    Anticancer Res; 2018 Aug; 38(8):4435-4441. PubMed ID: 30061207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX4-mediated FBW7 transcriptional upregulation confers Tamoxifen resistance in ER+ breast cancers via GATA3 downregulation.
    Sharma A; Thacker G; Mishra M; Singh AK; Upadhyay V; Sanyal S; Trivedi AK
    Life Sci; 2022 Aug; 303():120682. PubMed ID: 35662647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoparathyroidism, deafness, and renal dysplasia syndrome: 20 Years after the identification of the first GATA3 mutations.
    Lemos MC; Thakker RV
    Hum Mutat; 2020 Aug; 41(8):1341-1350. PubMed ID: 32442337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients.
    Afzaljavan F; Sadr AS; Savas S; Pasdar A
    Sci Rep; 2021 Jan; 11(1):1679. PubMed ID: 33462316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
    Jacquemier J; Charafe-Jauffret E; Monville F; Esterni B; Extra JM; Houvenaeghel G; Xerri L; Bertucci F; Birnbaum D
    Breast Cancer Res; 2009; 11(2):R23. PubMed ID: 19405945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
    Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
    J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
    Abba MC; Nunez MI; Colussi AG; Croce MV; Segal-Eiras A; Aldaz CM
    Breast Cancer Res; 2006; 8(6):R64. PubMed ID: 17078870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.